Loading…
ANI Pharmaceuticals, Inc. is projected to rise to $94.46 by 2027, a +15% move from its current price of $82.07. ANIP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $80.90 | $82.10 | $83.33 | +0.04% |
| Jul 14 | $80.44 | $82.14 | $83.88 | +0.09% |
| Jul 15 | $80.10 | $82.17 | $84.31 | +0.13% |
| Jul 16 | $79.81 | $82.21 | $84.68 | +0.17% |
| Jul 17 | $79.57 | $82.24 | $85.01 | +0.21% |
| Jul 18 | $79.35 | $82.28 | $85.31 | +0.26% |
| Jul 19 | $79.16 | $82.32 | $85.60 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $79.16 | $82.32 | $85.60 | +0.30% |
| Week 2 | $78.12 | $82.56 | $87.26 | +0.60% |
| Week 3 | $77.38 | $82.81 | $88.61 | +0.90% |
| Week 4 | $76.80 | $83.05 | $89.81 | +1.20% |
| Week 5 | $76.33 | $83.30 | $90.92 | +1.50% |
| Week 6 | $75.92 | $83.55 | $91.95 | +1.80% |
| Week 7 | $75.56 | $83.80 | $92.94 | +2.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc.
was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals, Inc. (ANIP) is currently priced at $85.05 and has a market cap of $1.93B.
Ranked 2053 by market cap, the company sits in a distinct position within the healthcare sector.
The forecast path shows a rising price outlook, with 2026 avg $85.05, 2027 avg $98.76, 2028 avg $118.40, 2029 avg $131.93, and 2030 avg $160.13.
Beyond 2030, the forecast envisions continued gains, with 2035 avg $237.82, 2040 avg $395.53, and 2050 avg $852.12; sentiment across these horizons is BULLISH.
A major floor 15.3% below — a decisive break under it would weaken the trend.
The nearest floor, 9.0% below — buyers have tended to step in here.
The nearest ceiling, 4.8% above — a clean break opens room to run.
A major ceiling 12.5% above — clearing it would confirm fresh momentum.
Key ANIP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANIP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $84.33 | Sell | $83.70 | Sell |
| MA 10 | $84.21 | Sell | $83.74 | Sell |
| MA 20 | $83.01 | Sell | $83.06 | Sell |
| MA 50 | $81.43 | Buy | $81.55 | Buy |
| MA 100 | $78.93 | Buy | $80.69 | Buy |
| MA 200 | $82.14 | Sell | $79.55 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.26 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -46.85 | Neutral |
| Williams %R (14) | -72.66 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -1.05 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 27.34 | Neutral |
| TRIX (15) | 0.18 | Buy |
| Awesome (5,34) | 2.61 | Buy |
| Ultimate (7,14,28) | 50.78 | Neutral |
| Momentum (10) | -1.21 | Sell |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 83.98 | Sell |
| ADX (14) | 12.87 | Neutral |
| ATR (14) | 1.20 | Info |
The 30-day technical picture is BULLISH.
RSI14 is 60, with SMA50 at $81.00 and SMA200 at $82.38.
Support is at $74.65 and resistance is at $86.03, with the 30-day price range spanning from $76.88 to $94.08.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $70.49 | $82.07 | $108.98 | 0% | Neutral | |
| $77.36 | $94.46 | $120.59 | +15% | Neutral | |
| $90.79 | $112.94 | $148.08 | +38% | Bullish | |
| $99.53 | $125.72 | $168.35 | +53% | Bullish | |
| $118.50 | $151.71 | $206.81 | +85% | Bullish | |
| $138.70 | $179.74 | $248.88 | +119% | Bullish | |
| $143.32 | $187.83 | $263.78 | +129% | Bullish | |
| $156.44 | $207.17 | $294.72 | +152% | Bullish | |
| $164.34 | $219.80 | $316.42 | +168% | Bullish | |
| $166.27 | $224.48 | $326.76 | +174% | Bullish | |
| $262.85 | $370.14 | $564.61 | +351% | Bullish | |
| $526.09 | $794.52 | $1,299.12 | +868% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $70.49 | $82.07 | $99.71 | +0.00% |
| August 2026 | $73.05 | $85.53 | $102.30 | +4.21% |
| September 2026 | $72.53 | $85.32 | $102.85 | -0.24% |
| October 2026 | $74.12 | $87.55 | $106.22 | +2.61% |
| November 2026 | $75.73 | $89.76 | $109.51 | +2.53% |
| December 2026 | $74.74 | $88.87 | $108.98 | -0.99% |
Click any year to see its month-by-month ANIP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ANIP could reach as high as $108.98, with a base case around $82.07 and support toward $70.49 — roughly 0% from $82.07. A consolidation phase looks the most probable path here.
Expect ANIP to range from $77.36 to $120.59 through 2027. The $94.46 average target implies a +15% move from current prices. That is up +15% on the projected 2026 average. Price action looks broadly range-bound.
The ANIP price prediction for 2028 points to an average of $112.94 (low $90.79, high $148.08) — a potential gain of +38% on today's $82.07. Buyers look set to stay in control over this stretch.
In 2029, ANIP is projected to trade between $99.53 and $168.35, averaging $125.72 — a potential gain of +53% from today's $82.07. That is up +11% on the projected 2028 average. Momentum favours further upside here.
ANI Pharmaceuticals, Inc.'s 2030 outlook centres on $151.71, within a $118.50 to $206.81 range. That is up +21% on the projected 2029 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ANIP could reach as high as $248.88, with a base case around $179.74 and support toward $138.70 — roughly +119% from $82.07. Momentum favours further upside here.
Expect ANIP to range from $143.32 to $263.78 through 2032. The $187.83 average target implies a +129% move from current prices. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ANIP price prediction for 2033 points to an average of $207.17 (low $156.44, high $294.72) — a potential gain of +152% on today's $82.07. Momentum favours further upside here.
In 2034, ANIP is projected to trade between $164.34 and $316.42, averaging $219.80 — a potential gain of +168% from today's $82.07. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
ANI Pharmaceuticals, Inc.'s 2035 outlook centres on $224.48, within a $166.27 to $326.76 range. That is up +2% on the projected 2034 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2040, ANIP could reach as high as $564.61, with a base case around $370.14 and support toward $262.85 — roughly +351% from $82.07. Buyers look set to stay in control over this stretch.
Expect ANIP to range from $526.09 to $1,299.12 through 2050. The $794.52 average target implies a +868% move from current prices. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ANIP today (≈ 12.18472 ANIP) could be worth
$9,680.99
+$8,680.99 (+868%) by 2050 · US Dollar
Based on the average projected ANIP price of $794.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANIPwould be worth at today's price.
$1,000 invested in ANIP on Jul 10, 2025 (≈ 15.128593 ANIP) would be worth
$1,241.6
+$241.6 (+24.2%) today · 1.24× · US Dollar
Based on a ANIP entry price of $66.1 vs. today's $82.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $86.03 | $953.97 | -4.6% |
| 1 month ago | $81.85 | $1,002.69 | +0.3% |
| 3 months ago | $78.36 | $1,047.35 | +4.7% |
| 6 months ago | $84.35 | $972.97 | -2.7% |
| 1 year ago | $66.1 | $1,241.6 | +24.2% |
| All time (5.0y) ago | $33.58 | $2,444.01 | +144.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANIP forecast.
Our base-case forecast reaches $160.00 around 2031.
Implied market cap at $160.00: $3.64B
By 2030, the average forecast is $160.13, with a min of $125.06 and a max of $218.32; ROI 88.3; sentiment BULLISH.
By 2040, the average forecast is $395.53, with a min of $280.86 and a max of $603.39; ROI 365.1; sentiment BULLISH.
By 2050, the average forecast is $852.12, with a min of $564.18 and a max of $1,393.39; ROI 901.9; sentiment BULLISH.
These are estimates and not guarantees, and actual results may vary due to a range of factors.
Tap a question to reveal the answer.
2030 avg $160.13, min $125.06, max $218.32; ROI 88.3; sentiment BULLISH.
Forecasts show rising averages and bullish sentiment from 2027 onward, with 2027 avg $98.76, 2028 avg $118.40, 2029 avg $131.93, 2030 avg $160.13; ROI values: 16.1, 39.2, 55.1, 88.3 respectively.
Yes—the 2030 max is $218.32.
RSI14 60; SMA50 $81.00; SMA200 $82.38; support $74.65; resistance $86.03; 30-day range from $76.88 to $94.08; sentiment BULLISH.
Current price $85.05; Market cap $1.93B; Rank 2053.
ANI Pharmaceuticals, Inc. Community Discussion
0Share your ANI Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.